Haleon plc (LON: HLN)
London
· Delayed Price · Currency is GBP · Price in GBX| Market Cap | 29.46B |
| Revenue (ttm) | 11.24B |
| Net Income (ttm) | 1.08B |
| Shares Out | 9.13B |
| EPS (ttm) | 0.12 |
| PE Ratio | 26.74 |
| Forward PE | 18.66 |
| Dividend | 0.06 (0.02%) |
| Ex-Dividend Date | Mar 14, 2024 |
| Volume | 11,764,605 |
| Open | 322.10 |
| Previous Close | 324.70 |
| Day's Range | n/a |
| 52-Week Range | 306.80 - 371.20 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | 36,856.00 (+11,324.67%) |
| Earnings Date | Aug 1, 2024 |
About Haleon
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops,... [Read more]
Financial Performance
In 2023, Haleon's revenue was 11.30 billion, an increase of 4.09% compared to the previous year's 10.86 billion. Earnings were 1.05 billion, a decrease of -1.04%.
Financial StatementsNews
Dr. Reddy's to Acquire Haleon's Nicotine Addiction Drug
Dr. Reddy's Laboratories (NYSE: RDY) has announced a definitive agreement with Haleon plc (NYSE: HLN) to acquire its global portfolio of consumer healthcare brands in the Nicotine Replacement Therap...
Dr Reddy’s to buy UK co’s nicotine gum biz for ₹5k cr
Dr Reddy’s Laboratories makes its biggest acquisition by buying British consumer healthcare giant Haleon's nicotine replacement therapy portfolio, excluding the US business, for approximately ₹5,275 c...
Dr Reddy's to acquire British consumer healthcare co Haleon's entire non-US nicotine therapy business
Dr Reddy's Laboratories is set to acquire Haleon Plc's NRT business, including Nicotinell, for GBP 500 million. The deal encompasses various NRT formats and potential contingent payments. This acquisi...
Haleon sells nicotine replacement therapy business outside of US for £500m
The healthcare giant said it was selling its nicotine replacement therapy business to a division of Indian drugmaker Dr Reddy’s Laboratories.
Haleon to sell overseas nicotine therapy business to Dr. Reddy’s
Haleon to sell nicotine replacement therapy business outside US for $633 mln
British consumer healthcare company Haleon said on Wednesday it would sell its nicotine replacement therapy business outside the United States to a unit of India's Dr. Reddy's for 500 million pounds (...
How the CMO role has evolved, according to Haleon's Katie Williams
Katie Williams, Haleon's US CMO, says the changing media landscape changes how CMOs operate. Williams was interviewed by Business Insider at the Cannes Lions 2024 International Festival of Creativity.
Yellow Wood Partners Portfolio Company Suave Brands Company Completes ChapStick Acquisition
BOSTON , June 3, 2024 /PRNewswire/ -- Yellow Wood Partners LLC ("Yellow Wood"), a Boston-based private equity firm known for investing in consumer brands and companies, is pleased to announce that its...
Indian pharma group readies swoop on anti-smoking aid Nicotinell
An Indian pharmaceutical group is closing in on a deal to snap up Nicotinell, the anti-smoking aid, from Haleon, its FTSE-100 parent company.
GSK sale of remaining Haleon stake nets more than $1.5B
GSK nets £1.2bn after selling final stake in Sensodyne maker Haleon
Haleon was spun out of GSK as a standalone business listed on the London Stock Exchange in July 2022.
GSK raises $1.5 bln from offloading Haleon stake at a discount
GSK has raised 1.25 billion pounds ($1.52 billion) from selling its entire remaining stake in consumer healthcare firm Haleon, the British drugmaker said on Friday.
GSK sells off remaining stake in Haleon
The sale of its 4.2 per cent holding is expected to raise around £1bn
GSK intends to sell its remaining stake in Haleon
British drugmaker GSK said on Thursday it plans to sell about 385 million shares, representing its entire shareholding, in spun-off consumer healthcare business Haleon.
GSK to sell entire Haleon stake
GSK (GSK) announces plans to sell its entire stake in consumer care company Haleon, following previous gradual reductions in ownership. Read more here.
Haleon: Pressures Are Temporary, But Closer To Fair Value
Haleon plc (HLN) Q1 2024 Earnings Call Transcript
Haleon plc (NYSE:NYSE:HLN) Q1 2024 Earnings Conference Call May 1, 2024 4:00 AM ETCompany ParticipantsSonya Ghobrial - Head, Investor RelationsTobias...
BUSINESS CLOSE: GSK raises guidance; Next exceeds forecasts; Aston Martin losses nearly double
Among the companies with reports and trading updates today are Next, GSK, Aston Martin Lagonda, Haleon, CVS Group, Smith & Nephew and Computacenter.
GSK ups 2024 guidance as HIV drugs and new vaccines boost its bottom line
The British drugmaker’s remaining 4.2% stake in its consumer health arm Haleon also boosted its bottom line, following its spin off in July 2022
Haleon's first-quarter revenue misses expectations
Consumer healthcare company Haleon's first-quarter revenue missed market estimates on Wednesday, due to retailer destocking in the U.S., and a cool down in demand for cold and flu medication after a s...
Haleon Keeps Outlook as Profits Rise
Haleon reported a 2% rise in underlying profits for the first quarter despite lower revenue, and maintained its full-year guidance and buyback plan.
Sensodyne maker Haleon to shut UK factory with loss of 435 jobs
The consumer healthcare group is aiming to close the site on a phased basis over the next two years.
Sensodyne-maker Haleon to shut UK manufacturing site, with more than 400 jobs hit
Consumer healthcare company Haleon is planning to shut down its manufacturing site in Britain by 2026, which will impact 435 jobs, a spokesperson told Reuters on Tuesday.
Companies Reporting: HSBC, Whitbread, Haleon, Apple
FTSE 350 and other selected companies reporting earnings for the week of 29th April include HSBC, Whitbread, Haleon and Apple
Dawn Allen Succeeds Tobias Hestler as CFO of Haleon
Consumer healthcare firm Haleon (HLN.L) announced on Wednesday the appointment of Dawn Allen as its new Chief Financial Officer, effective November 1st. Allen, at the age of 55, currently serves as CF...